Dengue Disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Aliases & Classifications for Dengue Disease

Sources:
²CDC, ¹¹Disease Ontology, ¹³DISEASES, ³⁰ICD10, ³²ICD9CM, ³⁵LifeMap Discovery®, ³⁸MedlinePlus, ³⁹MeSH, ⁴⁵NCIt, ⁴⁸NIH Rare Diseases, ⁵⁰Novoseek, ⁶²SNOMED-CT, ⁶⁸UMLS
See all MalaCards sources

Aliases & Descriptions for Dengue Disease:

Name: Dengue Disease ³⁵ ¹¹ ¹³

Dengue Fever ¹¹ ⁴⁸ ² ¹³ ⁶⁸

Dengue ⁵⁰ ³⁸ ³⁹

Dengue Shock Syndrome ⁴⁸ ⁶⁸

Df ⁴⁸ ²

Philippine Hemorrhagic Fever ⁴⁸

Singapore Hemorrhagic Fever ⁴⁸

Dengue Hemorrhagic Fever ⁴⁸

Dengue Virus Infection ⁴⁸

Thai Hemorrhagic Fever ⁴⁸

Hemorrhagic Dengue ⁴⁸

Classical Dengue ¹¹

Breakbone Fever ¹¹

Classic Dengue ¹¹

Severe Dengue ⁶⁸

Classifications:

MalaCards categories:
Global: Rare diseases, Infectious diseases

See all MalaCards categories (disease lists)

ICD10: ³⁰

Certain infectious and parasitic diseases

Arthropod-borne viral fevers and viral haemorrhagic fevers

Dengue fever [classical dengue]

External Ids:

Disease Ontology¹¹ DOID:12205

ICD10³⁰ A90

ICD9CM³² 061

SNOMED-CT⁶² 154345006, 266194002, 38362002

MeSH³⁹ D003715

NCIt⁴⁵ C34528

UMLS⁶⁸ C0011311

Summaries for Dengue Disease

Sources:
²CDC, ¹¹Disease Ontology, ³⁶MalaCards, ³⁸MedlinePlus
See all MalaCards sources

MedlinePlus:³⁸ Dengue is an infection caused by a virus. you can get it if an infected mosquito bites you. dengue does not spread from person to person. it is common in warm, wet areas of the world. outbreaks occur in the rainy season. dengue is rare in the united states. symptoms include a high fever, headaches, joint and muscle pain, vomiting, and a rash. in some cases, dengue turns into dengue hemorrhagic fever, which causes bleeding from your nose, gums, or under your skin. it can also become dengue shock syndrome, which causes massive bleeding and shock. these forms of dengue are life-threatening. there is no specific treatment. most people with dengue recover within 2 weeks. until then, drinking lots of fluids, resting and taking non-aspirin fever-reducing medicines might help. people with the more severe forms of dengue usually need to go to the hospital and get fluids. to lower your risk when traveling to areas where dengue is found wear insect repellent with deet wear clothes that cover your arms, legs and feet close unscreened doors and windows nih: national institute of allergy and infectious diseases

MalaCards based summary: Dengue Disease, also known as dengue fever, is related to dengue fever, protection against and dengue hemorrhagic fever, and has symptoms including fever, pruritus and gingival bleeding. An important gene associated with Dengue Disease is CD209 (CD209 Molecule), and among its related pathways are LDL Oxidation in Atherogenesis and CD209 (DC-SIGN) signaling. Affiliated tissues include skin, bone and eye, and related mouse phenotypes are hematopoietic system and immune system.

CDC:² With more than one-third of the world’s population living in areas at risk for infection, dengue virus is a leading cause of illness and death in the tropics and subtropics. As many as 400 million people are infected yearly. Dengue is caused by any one of four related viruses transmitted by mosquitoes. There are not yet any vaccines to prevent infection with dengue virus and the most effective protective measures are those that avoid mosquito bites. When infected, early recognition and prompt supportive treatment can substantially lower the risk of medical complications and death.

Disease Ontology:¹¹ A viral infectious disease that results in infection, has material basis in Dengue virus [NCBITaxon:12637] with four serotypes (Dengue virus 1, 2, 3 and 4), which are transmitted by Aedes mosquito bite. The infection has symptom fever, has symptom severe headache, has symptom severe pain behind the eyes, has symptom joint pain, has symptom muscle and bone pain, has symptom rash, and has symptom mild bleeding.

Related Diseases for Dengue Disease

Sources:
²⁰GeneAnalytics, ²¹GeneCards
See all MalaCards sources

Diseases related to Dengue Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 45)

id	Related Disease	Score	Top Affiliating Genes
1	dengue fever, protection against	12.3
2	dengue hemorrhagic fever	10.8
3	dengue shock syndrome	10.8
4	asymptomatic dengue	10.8
5	indomethacin antenatal infection	10.3	CD40LG, MBL2
6	tonsil cancer	10.3	CD40LG, ICAM1
7	trichostrongyloidiasis	10.2	CD40LG, PIK3C2A
8	dislocation of ear ossicle	10.2	CD40LG, ICAM1, VCAM1
9	erysipelas	10.2	CD40LG, RAF1
10	acute kidney tubular necrosis	10.2	CD40LG, PIK3C2A
11	erb-duchenne and dejerine-klumpke palsies	10.2	CCL5, ICAM1, VCAM1
12	pemphigus vulgaris, familial	10.2	CD40LG, ICAM1, VCAM1
13	orofacial granulomatosis	10.2	CCL5, ICAM1, VCAM1
14	mineral metabolism disease	10.2	CCL5, CD209, CD40LG
15	hyperimmunoglobulin syndrome	10.2	CCL5, CD209, CD40LG
16	hemorrhagic fever with renal syndrome	10.2	CD40LG, PIK3C2A
17	pigmentation disease	10.2	CCL5, ICAM1, VCAM1
18	cytokine receptor deficiency	10.2	IL11, THPO
19	bare lymphocyte syndrome, type i	10.2	CCL5, ICAM1, VCAM1
20	immunoglobulin g deficiency	10.2	CCL5, CD40LG, THPO
21	polg-related disorders	10.2	PTPN11, RAF1
22	israeli tick typhus	10.2	CCL5, CD40LG
23	anus leiomyosarcoma	10.2	CCL5, CD209, CD40LG
24	brown's tendon sheath syndrome	10.2	ICAM1, PIK3C2A, VCAM1
25	pseudomonas stutzeri infections	10.1	PTPN11, RAF1
26	eating disorder	10.1	CD40LG, ICAM1, VCAM1
27	hypopyon ulcer	10.1	ICAM1, VCAM1
28	acute chest syndrome	10.1	CCL5, CD40LG, ICAM1
29	craniopharyngioma	10.1	FCGR1A, ICAM1, VCAM1
30	microscopic breast papilloma	10.1	CD40LG, ICAM1, PIK3C2A
31	complex regional pain syndrome	10.1	CCL5, CD40LG, ICAM1
32	plantar fasciitis	10.1	CCL5, CD209, CD40LG, VCAM1
33	malignant peritoneal solitary fibrous tumor	10.1	CCL5, ICAM1, VCAM1
34	rdh12-related leber congenital amaurosis	10.1	PTPN11, RAF1
35	advanced sleep phase syndrome, familial, 1	10.1	CCL5, CD40LG, ICAM1, VCAM1
36	macrodactyly of the foot	10.1	ICAM1, VCAM1
37	heart valve disease	10.1	CD40LG, ICAM1, VCAM1
38	rectum squamous cell carcinoma	10.0	CCL5, CD40LG, MBL2, PIK3C2A
39	rheumatoid arthritis	10.0	CCL5, CD40LG, ICAM1, IL11, VCAM1
40	nemaline myopathy 2, autosomal recessive	9.8	CCL5, CD40LG, ICAM1, IL11, VCAM1
41	cousin syndrome	9.8	CCL5, CD40LG, FCGR1A, ICAM1, MBL2, VCAM1
42	endotheliitis	9.6
43	thrombocytopenia	9.5
44	hemorrhagic fever	9.5
45	dentinogenesis imperfecta	8.1	CCL5, CD209, CD40LG, FCGR1A, HCFC1, ICAM1

Graphical network of the top 20 diseases related to Dengue Disease:

Symptoms & Phenotypes for Dengue Disease

Sources:
¹¹Disease Ontology, ⁴¹MGI, ⁶⁴The Human Phenotype Ontology, ⁶⁸UMLS
See all MalaCards sources

Symptoms:

¹¹ (show all 7)

• fever
• severe headache
• severe pain behind the eyes
• joint pain

• muscle
• rash
• mild bleeding

Human phenotypes related to Dengue Disease:

⁶⁴ (show all 22)

id	Description	HPO Source Accession
1	gingival bleeding⁶⁴	HP:0000225
2	epistaxis⁶⁴	HP:0000421
3	petechiae⁶⁴	HP:0000967
4	bruising susceptibility⁶⁴	HP:0000978
5	skin rash⁶⁴	HP:0000988
6	pruritus⁶⁴	HP:0000989
7	lethargy⁶⁴	HP:0001254
8	cerebral hemorrhage⁶⁴	HP:0001342
9	ascites⁶⁴	HP:0001541
10	thrombocytopenia⁶⁴	HP:0001873
11	leukopenia⁶⁴	HP:0001882
12	fever⁶⁴	HP:0001945
13	diarrhea⁶⁴	HP:0002014
14	nausea and vomiting⁶⁴	HP:0002017
15	abdominal pain⁶⁴	HP:0002027
16	gastrointestinal hemorrhage⁶⁴	HP:0002239
17	hepatomegaly⁶⁴	HP:0002240
18	headache⁶⁴	HP:0002315
19	hypotension⁶⁴	HP:0002615
20	arthralgia⁶⁴	HP:0002829
21	hypoproteinemia⁶⁴	HP:0003075
22	cardiorespiratory arrest⁶⁴	HP:0006543

UMLS symptoms related to Dengue Disease:

fever, pruritus

MGI Mouse Phenotypes related to Dengue Disease according to GeneCards Suite gene sharing:

⁴¹

id	Description	MGI Source Accession	Score	Top Affiliating Genes
1	hematopoietic system	MP:0005397	8.1	CCL5, CD40LG, FCGR1A, ICAM1, MBL2, PIK3C2A
2	immune system	MP:0005387	7.3	CCL5, CD40LG, FCGR1A, ICAM1, MBL2, PIK3C2A

Drugs & Therapeutics for Dengue Disease

Sources:
¹BitterDB, ⁴ClinicalTrials, ⁷Cochrane Library, ¹⁰DGIdb, ¹⁴DrugBank, ²⁹HMDB, ³³IUPHAR, ⁴⁶NDF-RT, ⁵⁰Novoseek, ⁵⁶PharmGKB, ⁶⁸UMLS
See all MalaCards sources

Drugs for Dengue Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 59)

id

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Histamine

approved, investigational

Phase 4

1050

75614-87-8, 51-45-6

774

Synonyms:

.beta.-Imidazolyl-4-ethylamine

1H-Imidazole-4-ethanamine

1H-Imidazole-5-ethanamine

1avn

1qft

2-(1H-Imidazol-4-yl)ethanamine

2-(1H-Imidazol-4-yl)ethylamine

2-(1H-Imidazol-5-yl)ethanamine

2-(1H-Imidazol-5-yl)ethylamine

2-(1H-imidazol-4-yl)ethan-1-amine

2-(1H-imidazol-5-yl)ethanamine

2-(3H-Imidazol-4-yl)-ethylamine

2-(4-Imidazolyl)ethanamine

2-(4-Imidazolyl)ethylamine

2-(4-imidazolyl)ethylamine

2-Imidazol-4-yl-Ethylamine

2-Imidazol-4-ylethylamine

2-[4-Imidazolyl]ethylamine

4-(2-Aminoethyl)-1H-imidazole

4-(2-Aminoethyl)imidazole

4-Imidazoleethylamine

4-imidazoleethylamine

5-Imidazoleethylamine

5-imidazoleethylamine

51-45-6

53290_FLUKA

64422-25-9

924364-91-0

AC-13185

AC1L19ZT

AC1Q54BV

AC1Q54BW

AKOS000274386

ALBB-005968

BCBcMAP01_000250

BSPBio_001117

BSPBio_002124

Bio1_000487

Bio1_000976

Bio1_001465

Bio2_000389

Bio2_000869

C00388

CCRIS 6535

CHEBI:18295

CHEMBL90

CID774

D08040

DivK1c_000308

EINECS 200-100-6

Eramin

Ergamine

Ergotidine

F411C768-A159-4FC0-A195-291A08BB03AA

Free histamine

H7125_SIGMA

HMS1362G19

HMS1792G19

HMS1990G19

HSDB 3338

HSM

Histamine

Histamine (DCF)

Histamine Base

Histamine [USAN]

Histamine, Free Base

Histaminum

Histaminum (TN)

IDI1_000308

IDI1_002144

Imidazole-4-ethylamine

Istamina

Istamina [Italian]

KBio1_000308

KBio2_000457

KBio2_001325

KBio2_003025

KBio2_003893

KBio2_005593

KBio2_006461

KBio3_000853

KBio3_000854

KBio3_001344

KBioGR_000457

KBioGR_001580

KBioSS_000457

KBioSS_001325

L-Histamin base

L-Histamine

L-histamine

L000292

LS-75835

Lopac-H-7250

Lopac0_000595

MLS000069447

MolPort-001-785-597

MolPort-002-042-264

NCGC00015513-01

NCGC00015513-08

NCGC00093371-02

NCGC00093371-03

NCGC00093371-04

NCGC00093371-05

NINDS_000308

NSC 33792

NSC33792

SDCCGMLS-0066601.P001

SMP1_000151

SMR000059091

SPBio_000729

ST073926

STK346752

STOCK5S-55669

Spectrum2_000665

Spectrum3_000452

Spectrum4_000960

Spectrum5_000796

Spectrum_000845

Theramine

UNII-820484N8I3

WLN: T5M CNJ D2Z

ZERO/004089

[3H]histamine

b-Imidazolyl-4-ethylamine

beta-Aminoethylglyoxaline

beta-Aminoethylimidazole

beta-Aminothethylglyoxaline

beta-Imidazolyl-4-ethylamine

beta-aminoethylglyoxaline

beta-aminoethylimidazole

beta-aminothethylglyoxaline

bmse000744

histamine

nchembio.87-comp54

nchembio714-comp1

2

Ketotifen

approved

Phase 4

22

34580-14-8, 34580-13-7

3827

Synonyms:

10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (2E)-2-butenedioate (1:1)

116655-74-4

34580-13-7

4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one

4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one

4-(1-Methyl-4-piperidylidene)-9-hydrobenzo[a]thiopheno[3,2-d][7]annulen-10-one

4-(1-Methyl-piperidin-4-ylidene)-4,9-dihydro-1-thia-benzo[f]azulen-10-one

4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one

AB00053575

AC-15945

AC1L1GSZ

AKOS000541268

Alaway (TN)

BAS 00444483

BIDD:GT0509

BPBio1_000575

BRD-K28936863-051-05-8

BRN 3983897

BSPBio_000521

BSPBio_002964

C19H19NOS

CAS-34580-14-8

CHEBI:112957

CHEMBL534

CID3827

D08105

DB00920

DivK1c_000111

EINECS 252-099-7

HC 20-511

HMS2090F16

HSDB 7283

IDI1_000111

KBio1_000111

KBio2_000906

KBio2_003474

KBio2_006042

KBio3_002184

KBioGR_001289

KBioSS_000906

Ketotifen (INN)

Ketotifen Fumarate

Ketotifen [INN:BAN]

Ketotifene

Ketotifene [INN-French]

Ketotifene fumarate

Ketotifeno

Ketotifeno [INN-Spanish]

Ketotifenum

Ketotifenum [INN-Latin]

Ketotifin

Ketotiphen

Ketotiphene

L000753

LS-33820

Lopac-K-2628

Lopac0_000706

MolPort-001-933-278

NCGC00015580-01

NCGC00015580-02

NCGC00015580-03

NCGC00015580-09

NCGC00022572-02

NCGC00022572-04

NCGC00022572-05

NINDS_000111

Oprea1_335550

Oprea1_553550

Prestwick0_000371

Prestwick1_000371

Prestwick2_000371

Prestwick3_000371

SPBio_001275

SPBio_002442

STK048448

STOCK1S-14132

Spectrum2_001198

Spectrum3_001382

Spectrum4_000805

Spectrum5_001395

Spectrum_000426

Tocris-0784

UNII-X49220T18G

Zaditor

ketotifen

3

Vaccines

Phase 4, Phase 3, Phase 1, Phase 2

6611

4

Neurotransmitter Agents

Phase 4

18340

5

Anti-Allergic Agents

Phase 4

1522

6

Histamine Phosphate

Phase 4

1049

51-74-1

65513

Synonyms:

1H-Imidazole-4-ethanamine, phosphate (1:2)

2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)

4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)

4-(2-Aminoethyl)imidazole di-acid phosphate

4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate

51-74-1

53623-99-7

74-56-6

AC1L23E4

CID65513

D04445

DB00667

EINECS 200-118-4

H0147

Histamine acid phosphate

Histamine biphosphate

Histamine dihydrogen phosphate

Histamine diphosphate

Histamine phosphate (1:2)

Histamine phosphate (TN)

Histamine phosphate (USP)

Histamine phosphate [USP]

Histamine positive

LS-78569

UNII-QWB37T4WZZ

7

Antipruritics

Phase 4

841

8

Histamine Antagonists

Phase 4

961

9

Dermatologic Agents

Phase 4

5806

10

Histamine H1 Antagonists

Phase 4

791

11

Ivermectin

approved, vet_approved

Phase 2, Phase 3

61

70288-86-7

6474909, 46936176

Synonyms:

(2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside

22,23-Dihydroxy-avermectin B

22,23-Dihyroavermectin B1

5-O-Demethyl-22,23-dihydro-avermectin A1a

71827-03-7

AB00513813

AC1MJ4GR

AC1N7O27

BPBio1_000322

BRD-K24652731-001-02-7

BSPBio_000292

CHEMBL341047

CID11957587

CID4330618

CID6321424

CID6419971

CID6427057

EU-0100693

FT-0082656

HMS1568O14

HMS2089M09

I 8898

I8898_SIGMA

IVERMECTIN

Ivermectin

Ivermectina

Ivermectine

Ivermectinum

Lopac0_000693

MK-933

MLS001333247

MLS001333248

MLS002153248

MolPort-006-394-715

NCGC00094047-01

NCGC00094047-02

NCGC00094047-03

Prestwick2_000156

Prestwick3_000156

Prestwick_516

S1351_Selleck

SMR000857211

12

Antiparasitic Agents

Phase 2, Phase 3, Phase 1

2199

13

Anti-Infective Agents

Phase 2, Phase 3, Phase 1

22062

14

Protective Agents

Phase 3

7443

15

Pharmaceutical Solutions

Phase 3, Phase 2, Phase 1

8192

16

Insect Repellents

Phase 3

3

17

DEET

Phase 3

2

18

Heptavalent Pneumococcal Conjugate Vaccine

Phase 3, Phase 2

465

19

Ribavirin

approved

Phase 2

1003

36791-04-5

37542

Synonyms:

1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide

1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide

1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide

1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide

36791-04-5

437710-49-1

66510-90-5

AA-504/07617051

AB00430481

AC1L1XXZ

AC1Q1IDC

AC1Q4ZGS

AKOS001715163

BB_NC-0567

BPBio1_001195

BRN 0892462

BSPBio_001085

BSPBio_003352

C-Virin

CHEMBL1643

CID37542

Copegus

Copegus (TN)

Cotronak

D00423

DB00811

DRG-0028

DivK1c_000782

Drug: Ribavirin

EU-0101063

FT-0082885

HMS2090L15

HMS2094O09

HMS502H04

HSDB 6513

ICN-1229

IDI1_000782

KBio1_000782

KBio2_002328

KBio2_004896

KBio2_007464

KBio3_002854

KBioGR_001804

KBioSS_002331

KS-1104

LS-1241

Lopac0_001063

MLS000028486

MLS002222317

MolPort-002-507-104

MolPort-002-885-856

NCGC00090726-01

NCGC00090726-03

NCGC00090726-04

NCGC00090726-05

NCGC00090726-06

NCGC00090726-07

NINDS_000782

NSC 163039

NSC163039

Prestwick3_000993

R 9644

R-964

R9644_SIGMA

RBV

RG-964

RIBAV

RTC

RTCA

RTP

Ravanex

Rebetol

Rebetol (TN)

Rebetron

Rebretron

Ribacine

Ribamide

Ribamidil

Ribamidyl

Ribasphere

Ribasphere (TN)

Ribav

Ribavirin

Ribavirin (JAN/USP/INN)

Ribavirin Capsules

Ribavirin Triphosphate

Ribavirin [USAN:INN]

Ribavirin-TP

Ribavirina

Ribavirina [INN-Spanish]

Ribavirine

Ribavirine [INN-French]

Ribavirinum

Ribavirinum [INN-Latin]

Ribovirin

Ro 20-9963/000

Ro-20-9963

S2504_Selleck

SCH 18908

SMP1_000261

SMR000058315

SPECTRUM1503938

SR-01000076112-3

Spectrum3_001876

Spectrum4_001252

Spectrum5_002075

Spectrum_001826

Tribavirin

UNII-49717AWG6K

Varazid

Vilona

Viramid

Viramide

Virazid

Virazide

Virazole

Virazole (Ribavirin) Inhalation Solution

Virazole (TN)

Virazole 5'-triphosphate

ZINC01035331

ribavirin

20

Hydrocortisone

approved, vet_approved

Phase 2

667

50-23-7

5754, 657311

Synonyms:

(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione

(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione

11-Hydrocortisone

11-beta-Hydrocortisone

11-beta-Hydroxycortisone

11a-Hydroxycorticosterone

11alpha-Hydroxycorticosterone

11b,17,21-Trihydroxyprogesterone

11b-Hydrocortisone

11b-Hydroxycortisone

11beta,17,21-Trihydroxyprogesterone

11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione

11beta-Hydrocortisone

11beta-Hydroxycortisone

11beta-hydrocortisone

11β-hydrocortisone

17-Hydroxycorticosterone

17a-Hydroxycorticosterone

17alpha-Hydroxycorticosterone

2v95

4-Pregnen-11beta,17alpha,21-triol-3,20-dione

4-Pregnene-11alpha,21-triol 3,20-dione

4-Pregnene-11b,17a,21-triol-3,20-dione

50-23-7

8056-08-4

80562-38-5

8063-42-1

AC-12902

AC1L1L2B

ACETASOL HC

ACETIC ACID W/ HYDROCORTISONE

AI3-25006

AKOS001582651

Acticort

Acticort (TN)

Aeroseb HC

Aeroseb-HC

Ala-Cort

Ala-Scalp

Alacort

Algicirtis

Alphaderm

Amberin

Anflam

Anti-inflammatory hormone

Anucort

Anucort-HC

Anusol HC

Anusol HC (TN)

Aquacort

Aquanil HC

B48448A1-24BA-47CA-8D9E-43E5BC949386

BPBio1_000544

BRD-K93568044-001-03-1

BSPBio_000494

Balneol-hc

Barseb HC

Basan-Corti

Beta-hc

Bio-0648

C00735

C21H30O5

CCRIS 5854

CHEBI:17650

CHEMBL389621

CID5754

COR-OTICIN

CPD000653523

CaldeCORT Spray

Cetacort

Chronocort

Clear aid

Cleiton

Cobadex

Colocort

Colocort (TN)

Compound F

Compound F (kendall)

Cor-Tar-Quin

Corhydron

Cort-Dome

Cort-Quin

Cortanal

Cortef

Cortef (TN)

Cortenema

Cortesal

Corticreme

Cortifair

Cortifan

Cortifoam

Cortiment

Cortisol

Cortisol alcohol

Cortisol, Hydrocortisone

Cortisolonum

Cortisporin

Cortisporin Otico

Cortispray

Cortizol

Cortolotion

Cortonema

Cortoxide

Cortril

Cremesone

Cremicort-H

Cutisol

Cyclodextrin-encapsulated hydrocortisone

D00088

DB00741

DB07886

Delacort

Derm-Aid

Dermacort

Dermaspray

Dermil

Dermocortal

Dermolate

Dihydrocostisone

Dioderm

Dome-cort

Domolene-HC

Drotic

DuoCort

EINECS 200-020-1

EU-0100594

Ef corlin

Efcorbin

Efcortelan

Efcortelin

Eldecort

Eldercort

Epicort

Epicortisol

Epiderm H

Esiderm H

Evacort

Ficortril

Fiocortril

Flexicort

Foille Insetti

Genacort

Genacort (lotion)

Glycort

Gyno-Cortisone

H 4001

H-Cort

H0135_SIGMA

H0396_SIGMA

H0888_SIGMA

H3160_SIGMA

H4001_SIGMA

H6909_SIGMA

HC

HC #1

HC #4

HC (HYDROCORTISONE)

HMS1569I16

HMS2090M04

HSDB 3339

HYDROCORTISONE AND ACETIC ACID

HYDROCORTISONE IN ABSORBASE

Heb Cort

Heb-Cort

Hi-cor

Hidalone

Hidro-Colisona

Hidrocortisona

Hidrocortisona [INN-Spanish]

Hycort

Hycortol

Hycortole

Hydracort

Hydrasson

Hydro-Adreson

Hydro-Colisona

Hydro-RX

Hydro-colisona

Hydrocort

Hydrocortal

Hydrocorticosterone

Hydrocortisone

Hydrocortisone (JP15/USP/INN)

Hydrocortisone Acetate

Hydrocortisone Base

Hydrocortisone Butyrate

Hydrocortisone Sodium Phosphate

Hydrocortisone Valerate

Hydrocortisone [INN:BAN:JAN]

Hydrocortisone alcohol

Hydrocortisone base

Hydrocortisone free alcohol

Hydrocortisone solution

Hydrocortisone-Water Soluble

Hydrocortisonum

Hydrocortisonum [INN-Latin]

Hydrocortistab

Hydrocortisyl

Hydrocortone

Hydroskin

Hydroxycortisone

Hysone

Hytisone

Hytone

Hytone (TN)

Hytone lotion

Idrocortisone

Idrocortisone [DCIT]

Incortin-H

Incortin-hydrogen

Kendall'S compound F

Kendall's compound F

Komed HC

Kyypakkaus

LMST02030001

LS-7439

Lacticare HC

Lacticare-HC

Lactisona

Lopac0_000594

Lubricort

MLS000069609

MLS001148103

MLS002207135

MLS002222189

Maintasone

Medicort

Meusicort

Mildison

Milliderm

MolPort-001-794-637

NCGC00022848-06

NCGC00022848-07

NCGC00022848-09

NCGC00022848-12

NCI60_000118

NSC 10483

NSC-10483

NSC10483

Neo-Cort-Dome

Neo-Cortef

Neosporin-H Ear

Nogenic HC

Nutracort

Nystaform-HC

ORLEX HC

Optef

Otalgine

Otic-Neo-Cort-Dome

Otobiotic

Otocort

Otosone-F

Pediotic Suspension

Penecort

Permicort

Polcort H

Preparation H Hydrocortisone Cream

Prepcort

Prestwick0_000447

Prestwick1_000447

Prestwick2_000447

Prestwick3_000447

Prestwick_265

Prevex HC

Proctocort

Proctofoam

Proctozone HC

Protocort

Racet

Rectasol-HC

Rectoid

Reichstein'S substance M

Reichstein's substance M

Remederm HC

S1696_Selleck

SAM002264617

SMP1_000156

SMR000059022

SMR000653523

SPBio_002433

Sanatison

Scalp-Cort

Scalpicin Capilar

Schericur

Scheroson F

Sigmacort

Signef

Stie-cort

Stiefcorcil

Synacort

Systral Hydrocort

Tarcortin

Texacort

Texacort lotion 25

Timocort

Topicort

Transderma H

Traumaide

UNII-WI4X0X7BPJ

UPCMLD-DP133

UPCMLD-DP133:001

Uniderm

Vioform-Hydrocortisone

VoSol HC

Vytone

Zenoxone

[3H]cortisol

component of Lubricort

component of Neo-Cort-Dome

component of Otalgine

hydrocortisone

21

chloroquine

approved, vet_approved

Phase 1, Phase 2

149

54-05-7

2719

Synonyms:

( -)-Chloroquine

(+)-Chloroquine

(-)-Chloroquine

(R)-(-)-Chloroquine

3377 RP opalate

3545-67-3

50-63-5

54-05-7

56598-66-4

58175-86-3

58175-87-4

7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline

7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline

AB00053436

AC1L1EB8

AC1Q2ZA7

AC1Q2ZA8

Amokin

Aralen

Aralen HCl

Arechin

Arechine

Arequin

Arolen

Arthrochin

Artrichin

Avlochlor

Avloclor

BPBio1_000655

BRD-A91699651-065-01-1

BRN 0482809

BSPBio_000595

BSPBio_002001

Bemaco

Bemaphate

Bemasulph

Benaquin

Bipiquin

C07625

C18H26ClN3

CCRIS 3439

CHEBI:3638

CHEMBL76

CID2719

CQ

CU-01000012392-2

Capquin

Chemochin

Chingamin

Chloraquine

Chlorochin

Chlorochine

Chlorochinum

Chloroin

Chloroquin

Chloroquina

Chloroquine

Chloroquine (USP/INN)

Chloroquine (VAN)

Chloroquine Bis-Phosphoric Acid

Chloroquine Phosphate

Chloroquine [USAN:INN:BAN]

Chloroquine phosphate

Chloroquinium

Chloroquinum

Chloroquinum [INN-Latin]

Chlorquin

Cidanchin

Clorochina

Clorochina [DCIT]

Cloroquina

Cloroquina [INN-Spanish]

Cocartrit

D02366

DB00608

Dawaquin

Delagil

Dichinalex

DivK1c_000404

EINECS 200-191-2

Elestol

Gontochin

Gontochin phosphate

HMS2090O03

HSDB 3029

Heliopar

Hydroxychloroquine Sulfate

IDI1_000404

Imagon

Ipsen 225

Iroquine

KBio1_000404

KBio2_000592

KBio2_003160

KBio2_005728

KBio3_001221

KBioGR_000778

KBioSS_000592

Khingamin

Klorokin

LS-141726

Lapaquin

Lopac0_000296

Malaquin

Malaquin (*Diphosphate*)

Malaren

Malarex

Mesylith

Miniquine

MolMap_000009

MolPort-001-783-623

N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine

N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine

N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine

NCGC00015256-04

NCGC00162120-01

NCI60_000894

NINDS_000404

NSC 187208

NSC14050

NSC187208

Neochin

Nivachine

Nivaquine

Nivaquine B

Pfizerquine

Plaquenil

Prestwick0_000548

Prestwick1_000548

Prestwick2_000548

Prestwick3_000548

Quinachlor

Quinagamin

Quinagamine

Quinercyl

Quingamine

Quinilon

Quinoscan

RP 3377

RP-3377

Resochen

Resochin

Resoquina

Resoquine

Reumachlor

Reumaquin

Rivoquine

Ro 01-6014/N2

Ronaquine

Roquine

SMP2_000034

SN 6718

SN-7618

SPBio_000174

SPBio_002516

ST 21

ST 21 (pharmaceutical)

Sanoquin

Silbesan

Siragan

Solprina

Sopaquin

Spectrum2_000127

Spectrum3_000341

Spectrum4_000279

Spectrum5_000707

Spectrum_000132

Tanakan

Tanakene

Tresochin

Trochin

UNII-886U3H6UFF

W 7618

WIN 244

WLN: T66 BNJ EMY1&3N2&2 IG

chloroquine

nchembio.215-comp4

nchembio.368-comp8

nchembio.87-comp17

{4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine

22

Neomycin

approved, vet_approved

Phase 1, Phase 2

50

1404-04-2

8378

Synonyms:

(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside

(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol

11025-81-3

119-04-0

1393-86-8

1404-04-2

1405-10-3 (sulfate (salt))

4-18-00-07476 (Beilstein Handbook Reference)

72131_FLUKA

AB00443887

AC1L1QVH

Actilin

Actiline

Antibiotic 10676

Antibiotic produced by Streptomyces decaris. Neomycin B

Antibiotique

BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG

BDG-(1-4)NEB-(5-1)RIB-(3-1)NED

BPBio1_000326

BRN 0101621

BSPBio_000296

C01737

C23H46N6O13

C25H50N6O13

CCRIS 5462

CHEBI:7508

CID8378

Caswell No. 595

D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy

D05140

DB00452

DB00994

EINECS 204-292-2

EINECS 215-766-3

EPA Pesticide Chemical Code 006303

Endomixin

Enterfram

Fradiomycin

Fradiomycin B

Fradiomycinum

Framicetina

Framicetina [INN-Spanish]

Framycetin

Framycetin (INN)

Framycetin [INN:BAN:DCF]

Framycetine

Framycetine [INN-French]

Framycetinum

Framycetinum [INN-Latin]

Framygen

Fraquinol

HMS2089P15

HSDB 3242

LS-96091

LS-96095

MolPort-003-938-736

Myacine

Myacyne

Mycifradin

Myciguent

N1142_SIGMA

NCGC00179612-01

NEOMYCIN AND POLYMYXIN B SULFATES

NEOMYCIN B

NEOMYCIN SULFATE

NMY

Neo-Fradin

Neo-Rx

Neobiotic

Neobrettin

Neolate

Neomas

Neomcin

Neomicina

Neomicina [DCIT]

Neomin

Neomycin B Sulfate

Neomycin B sulfate

Neomycin Sulfate

Neomycin Sulphate

Neomycin solution

Neomycine

Neomycine [INN-French]

Neomycinum

Neomycinum [INN-Latin]

Nivemycin

PIMAVECORT

Prestwick3_000158

ST075177

Soframycin

Soframycin Ophthalmic

Soframycine

Tuttomycin

UNII-4BOC774388

UNII-I16QD7X297

USAF CB-19

VONAMYCIN

Vonamycin powder V

neomycin

23

Antiviral Agents

Phase 2

9967

24

Hydrocortisone acetate

Phase 2

667

25

Peripheral Nervous System Agents

Phase 1, Phase 2

23689

26

Hydrocortisone 17-butyrate 21-propionate

Phase 2

667

27

Cortisol succinate

Phase 2

667

28

Antimetabolites

Phase 2

12054

29

Chloroquine diphosphate

Phase 1, Phase 2

149

50-63-5

30

Analgesics, Non-Narcotic

Phase 1, Phase 2

6501

31

Analgesics

Phase 1, Phase 2

11733

32

Anti-Inflammatory Agents

Phase 1, Phase 2

10729

33

Anthelmintics

Phase 1, Phase 2

446

34

Antirheumatic Agents

Phase 1, Phase 2

10956

35

Anti-Inflammatory Agents, Non-Steroidal

Phase 1, Phase 2

4443

36

Antiprotozoal Agents

Phase 1, Phase 2

2051

37

Antimalarials

Phase 1, Phase 2

1246

38

Hemostatics

Phase 2

1443

39

Coagulants

Phase 2

1500

40

Antibodies

Phase 1, Phase 2

6394

41

Immunoglobulins

Phase 1, Phase 2

6394

42

Aluminum hydroxide

approved

Phase 1

210

21645-51-2

Synonyms:

Al(OH)3

Aluminium hydroxide

Aluminium hydroxide gel, dried

Aluminium hydroxide, dried

Aluminum hydroxide gel, dried

Aluminum hydroxide, dried

Dried aluminium hydroxide

Dried aluminum hydroxide gel

43

Gastrointestinal Agents

Phase 1

8402

44

Adjuvants, Immunologic

Phase 1

2554

45

Antacids

Phase 1

1842

46

Anti-Ulcer Agents

Phase 1

1842

47

Aluminum sulfate

Phase 1

92

48

Papaya

Nutraceutical

Phase 1

16

49

Acetaminophen

approved

1026

103-90-2

1983

Synonyms:

4'-Hydroxyacetanilide

4'-hydroxyacetanilide

4-(Acetylamino)phenol

4-Acetamidophenol

4-Acetaminophenol

4-Hydroxyacetanilide

4-Hydroxyanilid kyseliny octove

4-acetamidophenol

A-Per

A.F. Anacin

AC1Q1KYJ

AC1Q1KYK

APAP

Abenol

Abensanil

Abrol

Abrolet

Acamol

Accu-Tap

Acenol

Acephen

Acertol

Aceta Elixir

Aceta Tablets

Acetaco

Acetagesic

Acetalgin

Acetaminofen

Acetaminophen

Acetaminophen Uniserts

Acetamol

Acetavance

Acetofen

Actamin

Actamin Extra

Actamin Super

Actifed Plus

Actimol

Actimol Chewable Tablets

Actimol Children'S Suspension

Actimol Infants' Suspension

Actimol Junior Strength Caplets

Actron

Afebrin

Afebryl

Aferadol

Algesidal

Algina

Algomol

Algotropyl

Allay

Alpiny

Alpinyl

Alvedon

Amadil

Aminofen

Aminofen Max

Anacin

Anacin 3

Anacin-3

Anacin-3 Extra Strength

Anadin dla dzieci

Anaflon

Analter

Anapap

Andox

Anelix

Anexsia

Anexsia 10/660

Anexsia 5/325

Anexsia 7.5/325

Anexsia 7.5/650

Anhiba

Anoquan

Anti-Algos

Antidol

Anuphen

Apacet

Apacet Capsules

Apacet Elixir

Apacet Extra Strength Caplets

Apacet Extra Strength Tablets

Apacet Regular Strength Tablets

Apadon

Apamid

Apamide

Apitrelal

Apo-Acetaminophen

Arfen

Arthralgen

Asetam

Asomal

Aspac

Aspirin Free Anacin Maximum Strength Caplets

Aspirin Free Anacin Maximum Strength Gel Caplets

Aspirin Free Anacin Maximum Strength Tablets

Aspirin-Free Anacin

Aspirin-Free Excedrin Caplets

Asplin

Atasol

Atasol Caplets

Atasol Drops

Atasol Forte Caplets

Atasol Forte Tablets

Atasol Oral Solution

Atasol Tablets

Atralidon

Babikan

Bacetamol

Bancap

Bancap Hc

Banesin

Bayer Select

Bayer Select Allergy-Sinus

Bayer Select Head Cold

Bayer Select Headache Pain

Bayer Select Maximum Strength Headache Pain Relief Formula

Bayer Select Menstrual Multi-Symptom

Bayer Select Sinus Pain Relief

Ben-u-ron

Benmyo

Bickie-mol

Biocetamol

Bucet

Butalbital

Butapap

CCRIS 3

CHEBI:46195

Cadafen

Calapol

Calmanticold

Calonal

Calpol

Capital

Capital with Codeine

Captin

Causalon

Cefalex

Cetadol

Children'S Acetaminophen Elixir Drops

Children'S Acetaminophen Oral Solution

Children'S Tylenol Chewable

Claradol Codeine

Clixodyne

Co-Gesic

Cod-Acamol Forte

Codabrol

Codalgin

Codapane

Codicet

Codisal

Codisal Forte

Codoliprane

Codral Pain Relief

Cofamol

Conacetol

Contac Cough & Sore Throat Formula

Contra-Schmerz P

Coricidin

Coricidin D

Coricidin Sinus

Cosutone

Croix Blanche

Cuponol

Curadon

Curpol

Custodial

D oliprane

Dafalgan

Dapa

Dapa X-S

Darocet

Darvocet

Darvocet-N 50

Datril

Datril Extra-Strength

Daygrip

Demilets

Deminofen

Democyl

Demogripal

Desfebre

Dhamol

Dhc Plus

Dial-a-gesic

Dial-alpha-gesic

Dimindol

Dirox

Disprol

Dol-Stop

Dolcor

Dolefin

Dolegrippin

Dolene AP-65

Dolene Ap-65

Dolgesic

Doliprane

Dolko

Dolofugin

Doloreduct

Dolorfug

Dolorol Forte

Dolorstop

Dolotec

Dolprone

Dorocoff

Dresan

Dristan Cold No Drowsiness

Dristancito

Drixoral Plus

Duaneo

Dularin

Duorol

Duracetamol

Duradyne Dhc

Durapan

Dymadon

Dymadon Co

Dymadon Forte

Dypap

Ecosetol

Elixodyne

Empracet

Endecon

Enelfa

Eneril

Esgic

Esgic-Plus

Eu-Med

Excedrin

Excedrin Caplets

Excedrin Extra Strength Caplets

Excipain

Exdol

Exdol Strong

Fanalgic

Farmadol

Febranine

Febrectal

Febrectol

Febrex

Febricet

Febridol

Febrilix

Febrin

Febrinol

Febro-Gesic

Febrolin

Femcet

Fendon

Fensum

Fepanil

Fever All

Feverall

Feverall Junior Strength

Feverall Sprinkle Caps Junior Strength

Fevor

Finimal

Finiweh

Fioricet

Fluparmol

Fortalidon P

Freka-cetamol

Gattaphen T

Gelocatil

Geluprane

Genapap

Genapap Children'S Elixir

Genapap Children'S Tablets

Genapap Extra Strength Caplets

Genapap Extra Strength Tablets

Genapap Regular Strength Tablets

Genebs

Genebs Extra Strength Caplets

Genebs Regular Strength Tablets

Genebs X-Tra

Geralgine-P

Gripin Bebe

Grippostad

Gynospasmine

Hedex

Helon N

Homoolan

Hy-Phen

Hycomine Compound

Hydrocet

Ildamol

Inalgex

Infadrops

Infants' Feverall

Influbene N

Injectapap

Intensin

Janupap

Jin Gang

Junior Disprol

KBio1_000660

Kataprin

Kinder Finimal

Korum

Kratofin simplex

L024125

Labamol

Lekadol

Lemgrip

Lemsip

Lestemp

Liqiprine

Liquagesic

Liquigesic Co

Liquiprin

Liquiprin Children'S Elixir

Liquiprin Infants" Drops

Lonarid

Lonarid Mono

Lorcet-Hd

Lortab

Lupocet

Lyteca

Lyteca Syrup

Magnidol

Malex N

Malgis

Malidens

Maxadol

Medigesic Plus

Medinol Paediatric

Medocodene

Melabon Infantil

Mexalen

Midol Maximum Strength

Midol PM Night Time Formula

Midol Regular Strength

Midol Teen Formula

Migraleve Yellow

Minafen

Minoset

Miralgin

Momentum

Mono Praecimed

Multin

N-(4-Hydroxyphenyl)acetamide

N-Acetyl-4-aminophenol

N-Acetyl-p-aminophenol

N-acetyl-p-aminophenol

NAPA

NCX 701

NEBS

NSC3991

Naldegesic

Napafen

Napap

Naprinol

Nealgyl

Nebs

Neo-Fepramol

NeoCitran

Neodol

Neodolito

Neopap

Neotrend

Neuridon

New Cortal for Children

NilnOcen

Nina

No-Febril

Nobedon

Nodolex

Noral

Norcet

Norco

O-Acetaminophenol

Ofirmev

Oltyl

Oralgan

Oraphen-PD

Ortensan

Oxycet

Oxycocet

Oxycodone 2.5/Apap 500

Oxycodone 5/Apap 500

PCM Paracetamol Lichtenstein

Paceco

Pacemo

Pacemol

Pacet

Pacimol

Paedialgon

Paedol

Painex

Paldesic

Pamol

Panacete

Panadeine

Panadeine Co

Panadiene

Panado-Co

Panado-Co Caplets

Panadol

Panadol Extra Strength

Panadol Junior Strength Caplets

Panadol Maximum Strength Caplets

Panadol Maximum Strength Tablets

Panale ve

Panaleve

Panamax

Panasorb

Panasorbe

Panets

Panex

Panodil

Panofen

Pantalgin

Papa-Deine

Papa-Deine #3

Papa-Deine #4

Para-Suppo

Para-Tabs

Paracemol

Paracenol

Paracet

Paracetamol

Paracetamol AL

Paracetamol Antipanin P

Paracetamol BC

Paracetamol Basics

Paracetamol DC

Paracetamol Dr. Schmidgall

Paracetamol Fecofar

Paracetamol Genericon

Paracetamol Hanseler

Paracetamol Harkley

Paracetamol Heumann

Paracetamol Hexal

Paracetamol Italfarmaco

Paracetamol Nycomed

Paracetamol PB

Paracetamol Raffo

Paracetamol Ratiopharm

Paracetamol Rosch

Paracetamol Saar

Paracetamol SmithKline Beecham

Paracetamol Stada

Paracetamol Winthrop

Paracetamol von ct

Paracetamole

Paracetamolo

Paracetamolum

Paracetanol

Paracetol

Paracin

Paracod

Paracodol

Paracétamol

Parador

Paradrops

Parakapton

Parake

Paralen

Paralief

Paralink

Paralyoc

Paramol

Paramolan

Paranox

Parapan

Parasedol

Parasin

Paraspen

Parcetol

Parelan

Parmol

Parogal

Paroma

Pasolind

Pasolind N

Pe-Tam

Pediapirin

Pediatrix

Pedric

Percocet

Percocet-5

Percocet-Demi

Percogesic with Codeine

Perdolan Mono

Perfalgan

Phenaphen

Phenaphen Caplets

Phenaphen W/Codeine

Phendon

Phenipirin

Phogoglandin

Phrenilin

Phrenilin Forte

Pinex

Piramin

Pirinasol

Plicet

Polmofen

Predimol

Predualito

Prestwick_13

Prodol

Prompt

Prontina

Propacet

Propacet 100

Proval #3

Puernol

Pulmofen

Pyregesic-C

Pyrigesic

Pyrinazine

Pyromed

Quiet World

Redutemp

Reliv

Remedol

Rhinex D-Lay Tablets

Rivalgyl

Robigesic

Robitussin Night Relief

Rockamol Plus

Rounox

Roxicet

Roxicet 5/500

Roxilox

RubieMol

Rubophen

Rupemol

SK-Apap

SPBio_002836

Salzone

Sanicet

Sanicopyrine

Scanol

Scentalgyl

Scherzatabletten Rezeptur 534

Schmerzex

Sedalito

Sedapap

Semolacin

Servigesic

Seskamol

Setakop

Setamol

Setol

Sifenol

Sinaspril

Sine-Off Sinus Medicine Caplets

Sinedol

Sinmol

Sinubid

Snaplets-FR

Spalt N

Spalt fur die nacht

St Joseph Aspirin-Free

St Joseph Aspirin-Free for Children

St. Joseph Cold Tablets for Children

St. Joseph Fever Reducer

Stanback

Stopain

Sudafed Severe Cold Formula

Sudafed Sinus

Sunetheton

Supac

Supadol mono

Supofen

Suppap

Suppap-120

Suppap-325

Suppap-650

Supramol-M

Synalgos-Dc-A

TYL

Tabalgin

Tachiprina

Talacen

Tapanol

Tapanol Extra Strength Caplets

Tapanol Extra Strength Tablets

Tapar

Tavist Allergy/Sinus/Headache

Tazamol

Temlo

Tempanal

Tempra

Tempra Caplets

Tempra Chewable Tablets

Tempra D.S

Tempra Drops

Tempra Syrup

Tencon

Termacet

Termalgin

Termalgine

Termofren

TheraFlu

Tibinide

Tibizide

Tiffy

Tisin

Tisiodrazida

Titralgan

Tizide

Tocris-1706

Toximer P

Tralgon

Treupel N

Treupel mon

Treuphadol

Triad

Triaminic Sore Throat Formula

Triaprin

Tricoton

Tussapap

Ty lenol

Tycolet

Tylenol

Tylenol (TN)

Tylenol Allergy Sinus

Tylenol Arthritis Extended Relief

Tylenol Caplets

Tylenol Children'S Chewable Tablets

Tylenol Children'S Elixir

Tylenol Children'S Suspension Liquid

Tylenol Drops

Tylenol Elixir

Tylenol Extra Strength Adult Liquid Pain Reliever

Tylenol Extra Strength Caplets

Tylenol Extra Strength Gelcaps

Tylenol Extra Strength Tablets

Tylenol Gelcaps

Tylenol Infants Drops

Tylenol Infants" Suspension Drops

Tylenol Junior Strength Caplets

Tylenol Junior Strength Chewable Tablets

Tylenol Regular Strength Caplets

Tylenol Regular Strength Tablets

Tylenol Tablets

Tylex

Tylex CD

Tylol

Tylox

Tylox-325

Tymol

Ultracet

Upsanol

Utragin

Valadol

Valgesic

Valorin

Valorin Extra

Vanquish

Veralgina

Vermidon

Verpol

Viclor Richet

Vicodin

Vicodin Es

Vicodin Hp

Vips

Viruflu

Vivimed

Volpan

Wygesic

Zatinol

Zolben

acetaminofén

acétaminophène

alpha-Per

p-(Acetylamino)phenol

p-Acetamidophenol

p-Acetaminophenol

p-Acetylaminophenol

p-Hydroxyacetanilide

p-Hydroxyphenolacetamide

p-acetamidophenol

p-acetaminophenol

p-hydroxy-acetanilid

p-hydroxyacetanilide

p-hydroxyphenolacetamide

50

Artesunate

approved

185

88495-63-0

6917864, 5464098

Synonyms:

(3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-ol, hydrogen succinate

112346-66-4

182824-33-5

252637-87-9

4-Oxo-4-(((3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10-yl hydrogen butanedioate

4-oxo-4-{[(3r,5as,6r,8as,9r,10r,12r,12ar)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid

4-oxo-4-{[(5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid

83507-69-1

88495-63-0

91487-94-4

AC1L23PW

AC1L2XWW

AC1L4FU0

AC1Q5VRV

AKOS004119951

AS

Ambap88495-63-0

Arinate

Arsumax

Arsumax (TN)

Artesunate

Artesunate (USAN)

Artesunate (superseded RN)

Artesunato

Artesunato [INN-Spanish]

Artesunatum

Artesunatum [INN-Latin]

Artesunic acid

Artsuna

BB_NC-1045

Butanedioic acid, mono((3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester

Butanedioic acid, mono(decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester

C19H28O8

CHEMBL218601

CHEMBL258608

CID105031

CID11520210

CID11988384

CID156252

CID5464098

CID65664

CID6917864

CID9821433

CPD000466336

D02482

Dihydroartemisinine-12-alpha-succinate

Dihydroqinghaosusuccinate

Dihydroqinghasu hemsuccinate

FT-0082543

HMS2051I14

HMS2090L16

HSDB 7458

I06-0204

LS-177760

LS-187735

MLS000759445

MLS001424053

MolPort-001-732-325

MolPort-006-392-384

NCI60_039350

NSC712571

Nuartez

Plasmotrim

Plasmotrin

Qinghaozhi

Quinghaosu reduced succinate ester

S2265_Selleck

SAM001246628

SM 804

SMR000466336

STK801911

Succinyl dihydroartemisinin

UNII-60W3249T9M

WR 256283

WR-256283

artesunato

artesunatum

artesunic acid

butanedioic acid, 1-[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl] ester

dihydroqinghasu hemsuccinate

Interventional clinical trials:

(show top 50) (show all 157)

id	Name	Status	NCT ID	Phase
1	Ketotifen as a Treatment for Vascular Leakage During Dengue Fever	Recruiting	NCT02673840	Phase 4
2	Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study)	Recruiting	NCT02555072	Phase 4
3	Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)	Unknown status	NCT00966628	Phase 3
4	Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR	Unknown status	NCT00938379	Phase 3
5	Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia	Completed	NCT01254422	Phase 3
6	Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia	Completed	NCT01134263	Phase 3
7	Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers	Completed	NCT01411241	Phase 3
8	Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers	Completed	NCT01436396	Phase 3
9	Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine	Recruiting	NCT02406729	Phase 3
10	Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®	Recruiting	NCT02979535	Phase 3
11	Efficacy and Safety of Ivermectin Against Dengue Infection	Recruiting	NCT02045069	Phase 2, Phase 3
12	Study of INTERCEPT Blood System for Red Blood Cells in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS)	Recruiting	NCT03037164	Phase 3
13	Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia	Active, not recruiting	NCT01373281	Phase 3
14	Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America	Active, not recruiting	NCT01374516	Phase 3
15	Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children	Active, not recruiting	NCT02747927	Phase 3
16	Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects	Not yet recruiting	NCT02992418	Phase 3
17	Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®	Not yet recruiting	NCT02993757	Phase 3
18	The Effect of Chloroquine in the Treatment of Patients With Dengue	Unknown status	NCT00849602	Phase 1, Phase 2
19	Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms	Unknown status	NCT01973855	Phase 2
20	A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children	Completed	NCT00384670	Phase 1, Phase 2
21	A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants	Completed	NCT00322049	Phase 1, Phase 2
22	Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India	Completed	NCT01550289	Phase 2
23	A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines	Completed	NCT01064141	Phase 2
24	Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore	Completed	NCT00880893	Phase 2
25	Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America	Completed	NCT01187433	Phase 2
26	A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults	Completed	NCT00239577	Phase 2
27	A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children	Completed	NCT01843621	Phase 1, Phase 2
28	Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine	Completed	NCT01488890	Phase 2
29	Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine	Completed	NCT01943825	Phase 2
30	Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects	Completed	NCT00875524	Phase 2
31	Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US	Completed	NCT00617344	Phase 2
32	Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects	Completed	NCT00730288	Phase 2
33	Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America	Completed	NCT00993447	Phase 2
34	Efficacy and Safety of Dengue Vaccine in Healthy Children	Completed	NCT00842530	Phase 2
35	Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in Asia	Completed	NCT01218906	Phase 2
36	Study of Febrile Illness for Dengue-Endemic Areas in Latin America	Completed	NCT01293331	Phase 1, Phase 2
37	A Phase II Trial of a WRAIR Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults	Completed	NCT00350337	Phase 2
38	Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years	Completed	NCT00788151	Phase 2
39	Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)	Completed	NCT02193087	Phase 2
40	Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years	Completed	NCT01511250	Phase 2
41	Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults	Completed	NCT00740155	Phase 2
42	A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand	Completed	NCT00370682	Phase 2
43	Celgosivir as a Treatment Against Dengue	Completed	NCT01619969	Phase 1, Phase 2
44	A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children	Completed	NCT00468858	Phase 2
45	Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever	Completed	NCT01601613	Phase 2
46	The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans	Completed	NCT01943305	Phase 2
47	Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule	Recruiting	NCT02824198	Phase 2
48	Safety and Immunogenicity of Takeda's TDV in Healthy Children	Recruiting	NCT02948829	Phase 2
49	Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand	Recruiting	NCT02332733	Phase 2
50	Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults	Recruiting	NCT02421367	Phase 1, Phase 2

Search NIH Clinical Center for Dengue Disease

Cochrane evidence based reviews: dengue

Genetic Tests for Dengue Disease

Anatomical Context for Dengue Disease

Sources:
³⁶MalaCards
See all MalaCards sources

MalaCards organs/tissues related to Dengue Disease:

³⁶

Skin, Bone, Eye, Thyroid, Nk cells, Endothelial, Liver

Publications for Dengue Disease

Sources:
⁵⁷PubMed
See all MalaCards sources

Articles related to Dengue Disease:

(show top 50) (show all 86)

id	Title	Authors	Year
1	Dengue Disease Modelling and Forecasting: Utility and Limitations. (27292001)	Kalimuddin S.... Ooi E.E.	2016
2	Symptomatic Dengue Disease in Five Southeast Asian Countries: Epidemiological Evidence from a Dengue Vaccine Trial. (27532617)	Nealon J.... Bouckenooghe A.	2016
3	Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease. (27506852)	Scott L.J.	2016
4	Clinical and laboratory signs associated to severe dengue disease in hospitalized children. (27112034)	Pone S.M.... Brasil P.	2016
5	Relative Contribution of Dengue IgG Antibodies Acquired during Gestation or Breastfeeding in Mediating Dengue Disease Enhancement and Protection in Type I Interferon Receptor-Deficient Mice. (27341339)	Lee P.X.... Alonso S.	2016
6	Seasonal Distribution and Climatic Correlates of Dengue Disease in Dhaka, Bangladesh. (27114293)	Morales I.... Gurley E.S.	2016
7	High prevalence of clinically unsuspected dengue disease among children in Ribeirao Preto City, Brazil. (27004990)	Poloni T.R.... Aquino V.H.	2016
8	Early diagnosis of dengue disease severity in a resource-limited Asian country. (27670906)	Cavailler P.... Buchy P.	2016
9	Mannose-binding lectin gene (MBL2) polymorphisms related to the mannose-binding lectin low levels are associated to dengue disease severity. (27180198)	Figueiredo G.G.... Moura P.	2016
10	Dengue Disease Risk Mental Models in the City of Dhaka, Bangladesh: Juxtapositions and Gaps Between the Public and Experts. (26387980)	Dhar-Chowdhury P.... Driedger S.M.	2015
11	Antibody-enhanced dengue disease generates a marked CNS inflammatory response in the black-tufted marmoset Callithrix penicillata. (26303046)	Vasconcelos B.C.... Diniz D.G.	2015
12	Biomarkers of severe dengue disease - a review. (26462910)	John D.V.... Perng G.C.	2015
13	Epidemiological trends of dengue disease in Colombia (2000-2011): a systematic review. (25790245)	Villar L.A.... Sarti E.	2015
14	Dengue disease outbreak definitions are implicitly variable. (25979287)	Brady O.J.... Hay S.I.	2015
15	Epidemiological and demographic characteristics of dengue disease at a tertiary care centre in Saurashtra region during the year 2013. (26714509)	Mistry M.... Thakkar D.	2015
16	Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models. (26001278)	Tang W.W.... Shresta S.	2015
17	Antibodies against immature virions are not a discriminating factor for dengue disease severity. (25760350)	Rodenhuis-Zybert I.A.... Smit J.M.	2015
18	Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy. (26220099)	Flingai S.... Weiner D.B.	2015
19	Evolution of dengue disease and entomological monitoring in Santa Cruz, Bolivia 2002 - 2008. (25706631)	BrAcmond P.... Vargas J.	2015
20	Dengue disease surveillance: an updated systematic literature review. (24889501)	Runge-Ranzinger S.... Horstick O.	2014
21	Association between proinflammatory cytokines and lipid peroxidation in patients with severe dengue disease around defervescence. (24216294)	Soundravally R.... Kumar B.A.	2014
22	Epidemiological trends of dengue disease in Mexico (2000-2011): a systematic literature search and analysis. (25375162)	DantAcs H.G.... Sarti E.	2014
23	Dengue disease outbreak detection. (25160360)	Dayama P.... Sampath K.	2014
24	Epidemiology of dengue disease in malaysia (2000-2012): a systematic literature review. (25375211)	Mohd-Zaki A.H.... L'Azou M.	2014
25	CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice. (25217165)	Zellweger R.M.... Shresta S.	2014
26	Evaluation of the WHO classification of dengue disease severity during an epidemic in 2011 in the state of CearA!, Brazil. (24626308)	Cavalcanti L.P.... MourALo M.P.	2014
27	Reviewing the literature for epidemiological trends of dengue disease: introduction to a series of seven national systematic literature reviews. (25375830)	L'Azou M.... Sarti E.	2014
28	Dengue disease surveillance: improving data for dengue control. (25375232)	Horstick O.... Morrison A.C.	2014
29	NK Cells during Dengue Disease and Their Recognition of Dengue Virus-Infected cells. (24829565)	BeltrA!n D.... LA^pez-VergA"s S.	2014
30	Predictive symptoms and signs of severe dengue disease for patients with dengue fever: a meta-analysis. (25097856)	Zhang H.... Chen X.G.	2014
31	First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies. (24699622)	Ng J.K.... Alonso S.	2014
32	Epidemiology of Dengue Disease in the Philippines (2000-2011): A Systematic Literature Review. (25375119)	Bravo L.... L'Azou M.	2014
33	Epidemiological trends of dengue disease in Thailand (2000-2011): a systematic literature review. (25375766)	Limkittikul K.... L'Azou M.	2014
34	Atypical presentations of dengue disease in the elderly visiting the ED. (23399333)	Lee C.C.... Ko W.C.	2013
35	Epidemiological trends of dengue disease in Brazil (2000-2010): a systematic literature search and analysis. (24386496)	Teixeira M.G.... Joint G.	2013
36	Spatial distribution of dengue disease in municipality of MossorA^, Rio Grande do Norte, using the Geographic Information System. (24896274)	Bessa JA_nior F.N.... Pereira W.O.	2013
37	Comment on: "Atypical presentations of dengue disease in the elderly visiting the ED (24342867)	Arya S.C.... Agarwal N.	2013
38	Assessing weather effects on dengue disease in malaysia. (24287855)	Cheong Y.L.... Lakes T.	2013
39	Can non-human primates serve as models for investigating dengue disease pathogenesis? (24130557)	Clark K.B.... Villinger F.	2013
40	Knowledge, attitude, and practice of dengue disease among healthcare professionals in southern Taiwan. (23332425)	Ho T.S.... Liu C.C.	2013
41	The battle between infection and host immune responses of dengue virus and its implication in dengue disease pathogenesis. (23476150)	Sun P.... Kochel T.J.	2013
42	Dogma in classifying dengue disease. (23926138)	Farrar J.J.... Wills B.A.	2013
43	An optimal control problem arising from a dengue disease transmission model. (23274179)	Aldila D.... Soewono E.	2013
44	Association of human immune response to Aedes aegypti salivary proteins with dengue disease severity. (21995849)	Machain-Williams C.... Blair C.D.	2012
45	Simple Prognostic Criteria can Definitively Identify Patients who Develop Severe Versus Non-Severe Dengue Disease, or Have Other Febrile Illnesses. (22383925)	Falconar A.K.... Romero-Vivas C.M.	2012
46	Environmental influences on antibody-enhanced dengue disease outcomes. (23295753)	Diniz D.G.... Diniz C.W.	2012
47	Characterization of early host responses in adults with dengue disease. (21810247)	Tolfvenstam T.... Hibberd M.L.	2011
48	Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. (21811645)	Duong V.... Buchy P.	2011
49	Dengue disease status in Chennai (2006-2008): a retrospective analysis. (21441688)	Gunasekaran P.... Sheriff A.K.	2011
50	Unfolded protein response (UPR) gene expression during antibody-dependent enhanced infection of cultured monocytes correlates with dengue disease severity. (20858223)	Paradkar P.N.... Vasudevan S.G.	2011

Genes related to Dengue Disease

Sources:
¹³DISEASES, ²¹GeneCards, ⁵⁰Novoseek
See all MalaCards sources

Genes related to Dengue Disease:

(show all 16)

- Elite gene

- Cancer Census gene in COSMIC

id	Symbol	Description	Score	Implication	PubmedIds
1	CD209	CD209 Molecule	40.78	DISEASES inferred ¹³ Novoseek inferred ⁵⁰ GeneCards inferred via : Disorders, Publications (show sections)	12682107, 19941667, 16417930 more 19264337, 16239964, 15855154, 18593570, 16274635, 17005819, 18167547, 16469696
2	CD40LG	CD40 Ligand	33.52	DISEASES inferred ¹³ Novoseek inferred ⁵⁰ GeneCards inferred via : Disorders (show sections)	9431954, 19478396, 19858464 more 10973453, 14607869, 16914345, 11063489, 10391862, 15525913, 12853395, 17715330, 1297178, 12626461, 15956408, 9242317, 9646004, 12873179, 15184425, 16385170, 17898184, 10348250, 18940116, 10973469, 10572311, 9749624, 20089524, 19755928, 17257502, 9606000, 11724841, 9817913, 10473522, 17889487, 15498040, 17056582, 9455871, 9574674, 16210489, 9650956
3	VCAM1	Vascular Cell Adhesion Molecule 1	31.14	DISEASES inferred ¹³ GeneCards inferred via : Disorders, Publications (show sections)
4	ICAM1	Intercellular Adhesion Molecule 1	30.95	DISEASES inferred ¹³ GeneCards inferred via : Disorders, Publications (show sections)
5	MBL2	Mannose Binding Lectin 2	30.17	DISEASES inferred ¹³ GeneCards inferred via : Disorders, Publications (show sections)
6	THPO	Thrombopoietin	30.09	DISEASES inferred ¹³ GeneCards inferred via : Disorders, Publications (show sections)
7	CCL5	C-C Motif Chemokine Ligand 5	27.87	DISEASES inferred ¹³ Novoseek inferred ⁵⁰ GeneCards inferred via : Disorders (show sections)	11022000, 17416433, 15122797 more 16103156, 19837110
8	SULT1A3	Sulfotransferase Family 1A Member 3	26.14	DISEASES inferred ¹³ Novoseek inferred ⁵⁰ GeneCards inferred via : Disorders (show sections)	17006283
9	PIK3C2A	Phosphatidylinositol-4-Phosphate 3-Kinase Catalytic Subunit Type 2 Alpha	25.92	DISEASES inferred ¹³ Novoseek inferred ⁵⁰ GeneCards inferred via : Disorders (show sections)	8274073, 10191585
10	PTPN11	Protein Tyrosine Phosphatase, Non-Receptor Type 11	25.60	Novoseek inferred ⁵⁰ GeneCards inferred via : Disorders (show sections)	10928995, 12436482, 2149144 more 1849979, 18052531, 9191856, 12355369, 9268170, 19232866, 19592650, 18679379, 17319166, 9130232, 18788905, 19822367, 17329445, 2063952, 16122850, 16544248
11	RAF1	Raf-1 Proto-Oncogene, Serine/Threonine Kinase	25.02	DISEASES inferred ¹³ GeneCards inferred via : Disorders (show sections)
12	FCGR1A	Fc Fragment Of IgG Receptor Ia	24.77	DISEASES inferred ¹³ Novoseek inferred ⁵⁰ GeneCards inferred via : Disorders (show sections)	17005690, 10405359
13	HCFC1	Host Cell Factor C1	24.59	Novoseek inferred ⁵⁰ GeneCards inferred via : Disorders (show sections)	9649218, 11335136
14	IVNS1ABP	Influenza Virus NS1A Binding Protein	18.29	Novoseek inferred ⁵⁰ GeneCards inferred via : Disorders (show sections)	10698995, 11825945, 12853395 more 18471994, 9158059, 15184425, 18279077, 16140430, 15780810, 18439289, 16891505, 19122918, 19733994, 19264772, 16894199, 18685015, 19232392, 16103191, 18288598, 18714359, 17958746, 11596093, 19478848, 17653458
15	SENP8	SUMO/Sentrin Peptidase Family Member, NEDD8 Specific	17.56	DISEASES inferred ¹³ GeneCards inferred via : Disorders (show sections)
16	IL11	Interleukin 11	16.81	GeneCards inferred via : Disorders, Publications (show sections)

Variations for Dengue Disease

Expression for genes affiliated with Dengue Disease

Sources:
¹⁸Gene Expression Omnibus DataSets, ³⁵LifeMap Discovery®
See all MalaCards sources

Genes differentially expressed in tissues of Dengue Disease patients vs. healthy controls: ³⁵ (show all 93)

id	Gene	Description	Tissue	Up/Dn	Fold Change (log2)	P value
1	IFI27	interferon, alpha-inducible protein 27	Blood	+	4.85	0.000
2	RRM2	ribonucleotide reductase M2	Blood	+	4.48	0.000
3	CEP55	centrosomal protein 55kDa	Blood	+	4.33	0.000
4	BIRC5	baculoviral IAP repeat containing 5	Blood	+	4.30	0.000
5	XIST	X inactive specific transcript (non-protein coding)	Blood	-	4.25	0.009
6	CD38	CD38 molecule	Blood	+	4.23	0.000
7	DLGAP5	discs, large (Drosophila) homolog-associated protein 5	Blood	+	4.10	0.000
8	BUB1	BUB1 mitotic checkpoint serine/threonine kinase	Blood	+	4.08	0.000
9	IGHM	immunoglobulin heavy constant mu	Blood	+	4.04	0.000
10	MCM10	minichromosome maintenance 10 replication initiation factor	Blood	+	3.99	0.000
11	SHCBP1	SHC SH2-domain binding protein 1	Blood	+	3.97	0.000
12	PBK	PDZ binding kinase	Blood	+	3.97	0.000
13	TYMS	thymidylate synthetase	Blood	+	3.96	0.000
14	PI3	peptidase inhibitor 3, skin-derived	Blood	-	3.93	0.000
15	CDCA2	cell division cycle associated 2	Blood	+	3.91	0.000
16	SESN3	sestrin 3	Blood	-	3.90	0.000
17	HMMR	hyaluronan-mediated motility receptor (RHAMM)	Blood	+	3.83	0.000
18	MKI67	marker of proliferation Ki-67	Blood	+	3.83	0.000
19	ZWINT	ZW10 interacting kinetochore protein	Blood	+	3.83	0.000
20	DTL	denticleless E3 ubiquitin protein ligase homolog (Drosophila)	Blood	+	3.80	0.000
21	CDK1	cyclin-dependent kinase 1	Blood	+	3.78	0.000
22	NCAPG	non-SMC condensin I complex, subunit G	Blood	+	3.76	0.000
23	CDT1	chromatin licensing and DNA replication factor 1	Blood	+	3.76	0.000
24	SPC25	SPC25, NDC80 kinetochore complex component	Blood	+	3.75	0.000
25	CDC20	cell division cycle 20	Blood	+	3.73	0.000
26	CNTNAP3	contactin associated protein-like 3	Blood	-	3.72	0.000
27	TOP2A	topoisomerase (DNA) II alpha	Blood	+	3.71	0.000
28	NOV	nephroblastoma overexpressed	Blood	-	3.71	0.000
29	EIF1AY	eukaryotic translation initiation factor 1A, Y-linked	Blood	+	3.69	0.015
30	CCNB2	cyclin B2	Blood	+	3.62	0.000
31	CDKN3	cyclin-dependent kinase inhibitor 3	Blood	+	3.62	0.000
32	KIAA0101	KIAA0101	Blood	+	3.61	0.000
33	KIF2C	kinesin family member 2C	Blood	+	3.60	0.000
34	TK1	thymidine kinase 1, soluble	Blood	+	3.59	0.000
35	RPS4Y1	ribosomal protein S4, Y-linked 1	Blood	+	3.57	0.017
36	TTK	TTK protein kinase	Blood	+	3.56	0.000
37	CDC6	cell division cycle 6	Blood	+	3.56	0.000
38	CAV1	caveolin 1, caveolae protein, 22kDa	Blood	+	3.56	0.000
39	CENPA	centromere protein A	Blood	+	3.54	0.000
40	CYAT1	immunoglobulin lambda light chain-like	Blood	+	3.52	0.000
41	ASPM	abnormal spindle microtubule assembly	Blood	+	3.52	0.000
42	OR2W3	olfactory receptor, family 2, subfamily W, member 3	Blood	-	3.51	0.000
43	UHRF1	ubiquitin-like with PHD and ring finger domains 1	Blood	+	3.50	0.000
44	SELENBP1	selenium binding protein 1	Blood	-	3.50	0.000
45	GINS2	GINS complex subunit 2 (Psf2 homolog)	Blood	+	3.49	0.000
46	MELK	maternal embryonic leucine zipper kinase	Blood	+	3.47	0.000
47	BUB1B	BUB1 mitotic checkpoint serine/threonine kinase B	Blood	+	3.47	0.000
48	CHEK1	checkpoint kinase 1	Blood	+	3.46	0.000
49	CCNB1	cyclin B1	Blood	+	3.45	0.000
50	KIF11	kinesin family member 11	Blood	+	3.42	0.000
51	E2F8	E2F transcription factor 8	Blood	+	3.41	0.000
52	CCNA2	cyclin A2	Blood	+	3.40	0.000
53	KCTD14	potassium channel tetramerization domain containing 14	Blood	+	3.40	0.000
54	IGL	immunoglobulin lambda locus	Blood	+	3.37	0.000
55	IGLJ3	immunoglobulin lambda joining 3	Blood	+	3.35	0.000
56	CDCA5	cell division cycle associated 5	Blood	+	3.31	0.000
57	TPX2	TPX2, microtubule-associated	Blood	+	3.31	0.000
58	KIF20A	kinesin family member 20A	Blood	+	3.30	0.000
59	E2F7	E2F transcription factor 7	Blood	+	3.28	0.000
60	ANLN	anillin actin binding protein	Blood	+	3.28	0.000
61	KDM5D	lysine (K)-specific demethylase 5D	Blood	+	3.28	0.017
62	JAZF1	JAZF zinc finger 1	Blood	-	3.27	0.000
63	HJURP	Holliday junction recognition protein	Blood	+	3.25	0.000
64	IGKV3-20	immunoglobulin kappa variable 3-20	Blood	+	3.24	0.000
65	KIF4A	kinesin family member 4A	Blood	+	3.22	0.000
66	KIF15	kinesin family member 15	Blood	+	3.20	0.000
67	CNTNAP3B	contactin associated protein-like 3B	Blood	-	3.19	0.000
68	TNFRSF17	tumor necrosis factor receptor superfamily, member 17	Blood	+	3.19	0.000
69	AURKB	aurora kinase B	Blood	+	3.18	0.000
70	TRIP13	thyroid hormone receptor interactor 13	Blood	+	3.18	0.000
71	CCND2	cyclin D2	Blood	+	3.17	0.000
72	GINS1	GINS complex subunit 1 (Psf1 homolog)	Blood	+	3.16	0.000
73	IGLV2-23	immunoglobulin lambda variable 2-23	Blood	+	3.15	0.000
74	SLC6A8	solute carrier family 6 (neurotransmitter transporter), member 8	Blood	-	3.15	0.000
75	KIF18B	kinesin family member 18B	Blood	+	3.14	0.000
76	OIP5	Opa interacting protein 5	Blood	+	3.14	0.000
77	KRT1	keratin 1, type II	Blood	-	3.12	0.001
78	GGH	gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)	Blood	+	3.11	0.000
79	RAD51	RAD51 recombinase	Blood	+	3.10	0.000
80	GLDC	glycine dehydrogenase (decarboxylating)	Blood	+	3.10	0.000
81	RAD51AP1	RAD51 associated protein 1	Blood	+	3.09	0.000
82	DDX3Y	DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked	Blood	+	3.09	0.028
83	MBNL3	muscleblind-like splicing regulator 3	Blood	-	3.09	0.000
84	IGLV1-44	immunoglobulin lambda variable 1-44	Blood	+	3.09	0.000
85	MCM4	minichromosome maintenance complex component 4	Blood	+	3.08	0.000
86	IGLV4-60	immunoglobulin lambda variable 4-60	Blood	+	3.08	0.000
87	FOXM1	forkhead box M1	Blood	+	3.06	0.000
88	ESPL1	extra spindle pole bodies like 1, separase	Blood	+	3.06	0.000
89	SLC4A1	solute carrier family 4 (anion exchanger), member 1 (Diego blood group)	Blood	-	3.05	0.000
90	IGLV3-19	immunoglobulin lambda variable 3-19	Blood	+	3.04	0.000
91	GTSE1	G-2 and S-phase expressed 1	Blood	+	3.04	0.000
92	PDZK1IP1	PDZK1 interacting protein 1	Blood	-	3.02	0.000
93	USP18	ubiquitin specific peptidase 18	Blood	+	3.00	0.000

Search GEO for disease gene expression data for Dengue Disease.

Pathways for genes affiliated with Dengue Disease

Sources:
³⁴KEGG, ⁴²NCBI BioSystems Database, ⁵⁵PathCards, ⁵⁸QIAGEN, ⁵⁹R&D Systems, ⁶⁰Reactome, ⁶⁵Thomson Reuters
See all MalaCards sources

Pathways related to Dengue Disease according to GeneCards Suite gene sharing:

(show all 22)

id	Super pathways	Score	Top Affiliating Genes
1	LDL Oxidation in Atherogenesis⁵⁸	10.0	ICAM1, VCAM1
2	CD209 (DC-SIGN) signaling⁶⁰	9.8	CD209, RAF1
3	Photodynamic therapy-induced NF-kB survival signaling⁴² Show member pathways Immune response MIF-mediated glucocorticoid regulation⁶⁵	9.8	CD40LG, ICAM1, VCAM1
4	IgA-Producing B Cells in the Intestine⁵⁹	9.8	CD40LG, ICAM1, VCAM1
5	Malaria³⁴	9.8	CD40LG, ICAM1, VCAM1
6	NF-kappa B signaling pathway³⁴	9.8	CD40LG, ICAM1, VCAM1
7	TNF signaling pathway³⁴	9.7	CCL5, ICAM1, VCAM1
8	Staphylococcus aureus infection³⁴	9.5	FCGR1A, ICAM1, MBL2
9	Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers⁵⁹	9.5	CD209, IL11, THPO
10	Embryonic and Induced Pluripotent Stem Cell Differentiation Pathways and Lineage-specific Markers⁵⁹	9.4	IL11, THPO, VCAM1
11	Rheumatoid arthritis³⁴	9.4	CCL5, ICAM1, IL11
12	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell⁶⁰	9.3	CD40LG, FCGR1A, ICAM1, VCAM1
13	Hematopoietic cell lineage³⁴	9.2	FCGR1A, IL11, THPO
14	Development VEGF signaling via VEGFR2 - generic cascades⁶⁵ Show member pathways Development VEGF signaling and activation⁶⁵ VEGF - VEGF R2 Signaling Pathways⁵⁹	9.2	ICAM1, PTPN11, RAF1, VCAM1
15	Immune response_Role of integrins in NK cells cytotoxicity⁶⁵	9.2	ICAM1, PTPN11, RAF1, VCAM1
16	Interferon gamma signaling⁶⁰ Show member pathways Interferon Signaling⁶⁰ Regulation of IFNG signaling⁶⁰	9.2	FCGR1A, ICAM1, PTPN11, VCAM1
17	Interleukin-11 Signaling Pathway⁴²	8.9	ICAM1, IL11, PTPN11, RAF1
18	Jak-STAT signaling pathway (KEGG)³⁴ Show member pathways Jak-STAT signaling pathway³⁴ Interleukin-19, 20, 22, 24⁶⁰ IL-7 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types⁵⁹ B-Cell Development⁵⁸	8.9	IL11, PTPN11, RAF1, THPO
19	Class I MHC mediated antigen processing and presentation⁶⁰ Show member pathways Antigen processing- Ubiquitination and Proteasome degradation⁶⁰ Adaptive Immune System⁶⁰	8.3	CD209, CD40LG, FCGR1A, ICAM1, PTPN11, RAF1
20	Influenza A³⁴ Show member pathways Herpes simplex infection³⁴ Measles³⁴	7.8	CCL5, CD209, HCFC1, ICAM1, IVNS1ABP, PTPN11
21	Cytokine Signaling in Immune system⁶⁰ Show member pathways Signaling by Interleukins⁶⁰	7.7	CCL5, CD40LG, FCGR1A, ICAM1, IL11, PTPN11
22	Innate Immune System⁶⁰ Show member pathways Immune System⁶⁰ Neutrophil degranulation⁶⁰	7.2	CCL5, CD209, CD40LG, FCGR1A, ICAM1, IL11

GO Terms for genes affiliated with Dengue Disease

Sources:
¹⁹Gene Ontology
See all MalaCards sources

Cellular components related to Dengue Disease according to GeneCards Suite gene sharing:

id	Name	GO ID	Score	Top Affiliating Genes
1	external side of plasma membrane	GO:0009897	10.3	CD209, CD40LG, ICAM1, VCAM1
2	cell surface	GO:0009986	10.0	CD209, CD40LG, ICAM1, MBL2, VCAM1
3	extracellular space	GO:0005615	8.4	CCL5, CD40LG, ICAM1, IL11, MBL2, THPO

Biological processes related to Dengue Disease according to GeneCards Suite gene sharing:

(show all 14)

id	Name	GO ID	Score	Top Affiliating Genes
1	membrane to membrane docking	GO:0022614	10.7	ICAM1, VCAM1
2	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	GO:0007157	10.5	CD209, ICAM1, VCAM1
3	neurotrophin TRK receptor signaling pathway	GO:0048011	10.4	PTPN11, RAF1
4	cellular response to tumor necrosis factor	GO:0071356	10.4	CCL5, ICAM1, VCAM1
5	positive regulation of T cell proliferation	GO:0042102	10.4	CCL5, CD40LG, VCAM1
6	negative regulation of hormone secretion	GO:0046888	10.3	IL11, PTPN11
7	interferon-gamma-mediated signaling pathway	GO:0060333	10.2	FCGR1A, ICAM1, VCAM1
8	regulation of protein complex assembly	GO:0043254	10.2	HCFC1, PTPN11
9	B cell differentiation	GO:0030183	10.2	CD40LG, IL11, VCAM1
10	platelet activation	GO:0030168	10.2	CD40LG, PTPN11, RAF1
11	regulation of immune response	GO:0050776	9.9	CD40LG, FCGR1A, ICAM1, VCAM1
12	leukocyte cell-cell adhesion	GO:0007159	9.9	CCL5, CD209, CD40LG, ICAM1, VCAM1
13	positive regulation of ERK1 and ERK2 cascade	GO:0070374	9.5	CCL5, ICAM1, PTPN11, RAF1, THPO
14	viral process	GO:0016032	8.6	CD209, HCFC1, ICAM1, IVNS1ABP, VCAM1